BLOGS WEBSITE

TAG: therapeutics

Research Impact – Bench to bedside – CDK4/6 inhibitor for prostate cancer in trial

Reported in the journal Oncogene in 2013, Professor Lisa Butler (pictured left) and collaborators, including the Centre’s Professor Wayne Tilley and senior author, Professor Karen Knudsen from the Kimmel Cancer Center, Thomas Jefferson University in USA. inhibition of the cyclin/cyclin-dependent kinase/retinoblastoma (CDK4/6) pathway that is critical for cell replication may have a role in controlling some […]

Posted in News, Research | Tagged , , , |

Comments Off on Research Impact – Bench to bedside – CDK4/6 inhibitor for prostate cancer in trial

World experts convene to review ARvs and prostate cancer

The Journal European Urology has just published a summary of a special meeting arranged by the Prostate Cancer Foundation (USA) where stakeholders and 18 opinion leaders in the field from across the globe were invited to discuss androgen receptor variants (ARvs) in prostate cancer.  ARvs are an aberrant (or mutated) form of the androgen receptor.  The […]

Posted in News, Research | Tagged , , , |

Comments Off on World experts convene to review ARvs and prostate cancer

New potential targets for prostate cancer therapy

Dr Rajdeep Das,  FFCMH PhD Scholarship student in the Dame Roma Mitchell Cancer Research Laboratories, has received a Dean’s letter of commendation for his thesis on microRNAs (small fragments of genetic material that regulate how genes are expressed in cells) and prostate cancer. Raj has recently taken up a new position as a postdoctoral scientist at the University […]

Posted in News, Research | Tagged , , , , |

Comments Off on New potential targets for prostate cancer therapy

Hsp90 inhibitors and their therapeutic potential in prostate cancer

A/Professor Lisa Butler (ARC Future Fellow, Prostate Cancer Research Group Leader, SAHMRI),  Dr Margaret Centenera (PCFA Post-doctoral Research Fellow) and PhD student Heather Armstrong were invited along with UK colleagues  Dr. Roberta Ferraldeschi and Professor Paul Workman from The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research in the UK, to publish a review […]

Posted in Research | Tagged , , |

Comments Off on Hsp90 inhibitors and their therapeutic potential in prostate cancer